tiprankstipranks
Trending News
More News >
pc:allos

Allos AI

Allos AI applies Causal AI to reformulate complex small-molecule drugs by modeling how formulation, dosing, delivery, and patient biology interact to drive clinical outcomes. The company partners with pharmaceutical developers and generic manufacturers to modernize legacy assets, design more interpretable clinical studies using real-world evidence, and advance complex generics and high-risk NCE programs.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$5M
Total Amount Raised$5M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$5M
Latest Funding Amount$5M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 12, 2026
Seed Round
$5.00M

Investors

Investor Name
Funding Round

Related News and Analysis